QBD Approach to Predict the in-vivo Performance Based on in-vitro Results using Mucuna pruriens Seed Mucilage as a Novel Tablet Dosage Form Excipient and Dicofenac Sodium as Model drug Candidate (Record no. 15523)

000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211120140618.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211120b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 14691
Author Deokar, Gitanjali Sambhajirao
245 ## - TITLE STATEMENT
Title QBD Approach to Predict the in-vivo Performance Based on in-vitro Results using Mucuna pruriens Seed Mucilage as a Novel Tablet Dosage Form Excipient and Dicofenac Sodium as Model drug Candidate
250 ## - EDITION STATEMENT
Volume, Issue number Vol.55(3), Jul-Sep
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Banagalore
Name of publisher, distributor, etc. Association of Pharmaceutical Teachers of India (APTI)
Year 2021
300 ## - PHYSICAL DESCRIPTION
Pagination 715-727p.
520 ## - SUMMARY, ETC.
Summary, etc. Background: Aim of the present study was to put forth certain modifications in Quality by design approach to predict the in-vivo performance of dosage form based on in-vivo performance parameter simulation using in-vitro experimentations. Materials and Methods: One factor design was used with prime focus on impact of Mucuna pruriens seed mucilage as excipient on dosage form functionality and applicability. During product development stage, apart from manufacturing variables other impacting parameters considered were GI pH, alterations in body temperature and GI motility. Factors considered were simulated pH, Temperature and RPM (Rotations per minutes) variations. Process flow worksheet was developed. QTPP (Quality target product profile) and CQA (Critical Quality Attributes) data was generated. Results: Risk assessment and Ishikawa diagram (Cause and effect analysis) were found to be helpful to generate the results predicting in vivo performance of dosage from. The process capability indices helped for judging product/process performance. The study design could be helpful to analyze the alterations in in-vivo performance based on excipient behavior in simulated conditions tested in-vitro. Conclusion: The present research work has successfully used Quality by design approach to predict the in-vivo performance of Tablet dosage form based on in-vitro data simulation. It can be concluded that study design with more number of simulating variables could be helpful pattern to come up with in-vivo performance predictions.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4639
Topical term or geographic name entry element PHARMACEUTICS
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 14692
Co-Author Kakulte, Harshada Dnyandeo
773 0# - HOST ITEM ENTRY
International Standard Serial Number 0019-5464
Place, publisher, and date of publication Bengluru Association of Pharmaceutical Teachers of India (APTI)
Title Indian journal of pharmaceutical education and research
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.ijper.org/sites/default/files/IndJPhaEdRes-55-3-715.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Shelving location Date acquired Barcode Date last seen Price effective from Koha item type
          School of Pharmacy School of Pharmacy Archieval Section 2021-11-20 2021-2022328 2021-11-20 2021-11-20 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha